0001571049-14-006678.txt : 20141120
0001571049-14-006678.hdr.sgml : 20141120
20141120211919
ACCESSION NUMBER: 0001571049-14-006678
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20141120
FILED AS OF DATE: 20141120
DATE AS OF CHANGE: 20141120
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: APPLIED DNA SCIENCES INC
CENTRAL INDEX KEY: 0000744452
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISCELLANEOUS BUSINESS SERVICES [7380]
IRS NUMBER: 592262718
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 50 HEALTH SCIENCES DRIVE
CITY: STONY BROOK
STATE: NY
ZIP: 11790
BUSINESS PHONE: 631-240-8800
MAIL ADDRESS:
STREET 1: 50 HEALTH SCIENCES DRIVE
CITY: STONY BROOK
STATE: NY
ZIP: 11790
FORMER COMPANY:
FORMER CONFORMED NAME: PROHEALTH MEDICAL TECHNOLOGIES INC
DATE OF NAME CHANGE: 20010504
FORMER COMPANY:
FORMER CONFORMED NAME: DCC ACQUISITION CORP
DATE OF NAME CHANGE: 19990211
FORMER COMPANY:
FORMER CONFORMED NAME: DATALINK CAPITAL CORP/TX/
DATE OF NAME CHANGE: 19980306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hayward James A
CENTRAL INDEX KEY: 0001357784
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36745
FILM NUMBER: 141240576
MAIL ADDRESS:
STREET 1: C/O 25 HEALTH SCIENCES DRIVE
STREET 2: SUITE 113
CITY: NEW YORK
STATE: NY
ZIP: 11790
4
1
t1402309-x2_hayward.xml
OWNERSHIP DOCUMENT
X0306
4
2014-11-20
0
0000744452
APPLIED DNA SCIENCES INC
APDN
0001357784
Hayward James A
50 HEALTH SCIENCES DRIVE
STONY BROOK
NY
11790
1
1
1
0
Chairman, CEO and President
Common Stock
2014-11-20
4
J
0
315171
A
1842331
D
Common Stock
2014-11-20
4
P
0
76923
3.24
A
1919254
D
Warrants
3.50
2014-11-20
4
J
0
315171
A
2019-11-20
Common Stock
315171
315171
D
Warrants
3.50
2014-11-20
4
P
0
76923
0.01
A
2019-11-20
Common Stock
76923
392094.00
D
The reporting person was the holder of a 12.5% Promissory Note dated as of September 11, 2014 issued by Applied DNA Sciences, Inc. (the "Issuer") to the reporting person in the original principal amount of $1,000,000. The Promissory Note, together with accrued interest, was exchanged (for no additional consideration) for shares of the Common Stock and Warrants to purchase Common Stock immediately prior to the closing of the Issuer's public offering pursuant to its Registration Statement on Form S-1 (File No. 333-199121), in an amount determined by the quotient obtained by dividing the outstanding principal and interest of the Promissory Note by $3.25 (the price of the Common Stock and Warrants sold in the public offering).
Represents shares of the Issuer's common stock and Warrants purchased at the public offering price of $3.24 per common share and $0.01 per Warrant.
These warrants are fully exercisable.
/s/ Karol Kain Gray, Attorney-in-Fact
2014-11-20